LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy

Luetke, 2014, Osteosarcoma treatment - where do we stand? A state of the art review, Cancer Treat Rev, 40, 523, 10.1016/j.ctrv.2013.11.006 Hattinger, 2021, Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies, Cancers, 13, e2878, 10.3390/cancers13122878 Kim, 2017, GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy, Autophagy, 13, 149, 10.1080/15548627.2016.1239676 Lilienthal, 2020, Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies, Int J Mol Sci, 21, e6885, 10.3390/ijms21186885 Ponting, 2009, Evolution and functions of long noncoding RNAs, Cell, 136, 629, 10.1016/j.cell.2009.02.006 He, 2019, Emerging roles of lncRNAs in the post-transcriptional regulation in cancer, Genes Dis, 6, 6, 10.1016/j.gendis.2019.01.003 Gibb, 2011, The functional role of long non-coding RNA in human carcinomas, Mol Cancer, 10, e38, 10.1186/1476-4598-10-38 Ahadi, 2021, Functional roles of lncRNAs in the pathogenesis and progression of cancer, Genes Dis, 8, 424, 10.1016/j.gendis.2020.04.009 Chen, 2020, LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway, Eur Rev Med Pharmacol Sci, 24, 581 Shen, 2019, LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1, J Cell Physiol, 234, 13464, 10.1002/jcp.28026 Huang, 2019, Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma, J Cell Physiol, 234, 18408, 10.1002/jcp.28476 Huang, 2018, Prognostic value of programmed cell death 1 ligand-1 (PD-L1) or PD-1 expression in patients with osteosarcoma: a meta-analysis, J Cancer, 9, 2525, 10.7150/jca.25011 Barbee, 2015, Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology, Ann Pharmacother, 49, 907, 10.1177/1060028015586218 Ackermann, 2020, First-line immune checkpoint inhibition for advanced non-small-cell lung cancer: state of the art and future directions, Drugs, 80, 1783, 10.1007/s40265-020-01409-6 Shen, 2019, Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies, Genes Dis, 6, 232, 10.1016/j.gendis.2019.06.006 Jiang, 2021, Immune checkpoint: the novel target for antitumor therapy, Genes Dis, 8, 25, 10.1016/j.gendis.2019.12.004 Waniczek, 2017, Tumor-associated macrophages and regulatory T cells infiltration and the clinical outcome in colorectal cancer, Arch Immunol Ther Exp, 65, 445, 10.1007/s00005-017-0463-9 Zhang, 2018, Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer, Ann Surg, 267, 311, 10.1097/SLA.0000000000002058 Isakoff, 2015, Osteosarcoma: current treatment and a collaborative pathway to success, J Clin Oncol, 33, 3029, 10.1200/JCO.2014.59.4895 Pan, 2021, Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1, Nat Commun, 12, e4960, 10.1038/s41467-021-24845-8 Zheng, 2018, Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN, Cell Death Dis, 9, e253, 10.1038/s41419-018-0305-7 Jin, 2018, Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer, Cell Death Dis, 9, e1017, 10.1038/s41419-018-1064-1 Wang, 2017, LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis, OncoTargets Ther, 10, 5137, 10.2147/OTT.S146423 Ma, 2017, Long non-coding RNA MEG3 contributes to cisplatin-induced apoptosis via inhibition of autophagy in human glioma cells, Mol Med Rep, 16, 2946, 10.3892/mmr.2017.6897 Wang, 2018, Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis, Biomed Pharmacother, 106, 1607, 10.1016/j.biopha.2018.07.131 Feng, 2018, Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells, Neoplasma, 65, 925, 10.4149/neo_2018_180125N55 Mowers, 2017, Autophagy in cancer metastasis, Oncogene, 36, 1619, 10.1038/onc.2016.333 Levy, 2017, Targeting autophagy in cancer, Nat Rev Cancer, 17, 528, 10.1038/nrc.2017.53 Wirawan, 2012, Autophagy: for better or for worse, Cell Res, 22, 43, 10.1038/cr.2011.152 Mrakovcic, 2018, p53-mediated molecular control of autophagy in tumor cells, Biomolecules, 8, e14, 10.3390/biom8020014 White, 2015, The role for autophagy in cancer, J Clin Invest, 125, 42, 10.1172/JCI73941 Cadwell, 2016, Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis, Nat Rev Immunol, 16, 661, 10.1038/nri.2016.100 Liao, 2019, Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma, Int J Oncol, 55, 1213